Related Experiment Videos
Basal cell carcinoma with annular leukoderma mimicking leukoderma acquisitum centrifugum
Archives of Dermatology
|March 1, 1980
Summary
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Efficacy of adjuvant therapy in patients with stage IIIA cutaneous melanoma.
Annals of oncology : official journal of the European Society for Medical Oncology·2025
Single-agent anti-PD-1 or combined with ipilimumab in patients with mucosal melanoma: an international, retrospective, cohort study.
Annals of oncology : official journal of the European Society for Medical Oncology·2022
Delayed immune-related adverse events with anti-PD-1-based immunotherapy in melanoma.
Annals of oncology : official journal of the European Society for Medical Oncology·2021
Association of clinical factors and recent anticancer therapy with COVID-19 severity among patients with cancer: a report from the COVID-19 and Cancer Consortium.
Annals of oncology : official journal of the European Society for Medical Oncology·2021
Management of early melanoma recurrence despite adjuvant anti-PD-1 antibody therapy☆.
Annals of oncology : official journal of the European Society for Medical Oncology·2020
Comparison of Early and Late Latent Syphilis- Colorado, 1991.
Archives of dermatology·2016
Case of Rhinoscleroma.
Archives of dermatology·2016
Cutaneous Fungal Infections.
Archives of dermatology·2016
An Ulcerated Plaque in a Gay Man.
Archives of dermatology·2016
Solitary Violaceous Nodule on the Face.
Archives of dermatology·2016
Erythematous Plaques on the Eyelids.
Archives of dermatology·2016
Development of cecal volvulus after redo pancreas transplantation.
Journal of surgical case reports·2026
Primary Diffuse Large B-Cell Lymphoma of the External Auditory Canal with Extensive Local Extension: A Case Report and Literature Review.
Iranian journal of otorhinolaryngology·2026
Comparison of variably specific Bruton tyrosine kinase inhibitors on platelet aggregation mediated by Fcγ receptor (FcγR) IIa, glycoprotein VI, and platelet endothelial aggregation receptor (PEAR) 1: implications for Bruton tyrosine kinase inhibitors as antithrombotic therapy.
Research and practice in thrombosis and haemostasis·2026